Plunkett Research Online: LAVA Therapeutics NV

LAVA THERAPEUTICS NV (LVTX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipel.....


LAVA THERAPEUTICS NV

Ticker: LVTX
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 31 630003035
Fax:
Address: Yalelaan 60
Utrecht, UT 3584 CM Netherlands

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Stephen HurlyCEO/Director/President
Fred PowellCFO
See More
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipel.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture